Skip to main content

Advertisement

SpringerLink
Log in

Subcutaneous Mycoses in Travelers

  • Skin and Soft Tissue Infections in Returning Travelers from the Tropics (C Franco-Paredes, Section Editor)
  • Published:
Current Tropical Medicine Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The increase in international travel in recent decades has contributed to the risk of acquiring diseases considered endemic to a region or country and the change in the epidemiology of these diseases. Endemic mycoses that may be acquired by travelers in the short or long term are endemic subcutaneous mycoses such as sporotrichosis and lobomycosis, while endemic systemic mycoses are a group of serious diseases including histoplasmosis and coccidioidomycosis. Herein, we review the current knowledge and highlight the most important aspects of these fungal infections in travelers.

Recent Findings

The most relevant advances in the study of these mycoses involve the epidemiological distribution; human mycoses can be fatal and there are few antifungal drugs available, increasing drug resistance, and a risk of emerging fungal diseases associated with climate change, as well as the increasing virulence, and the diagnostic strategies that may be limited in many countries.

Summary

Although endemic mycoses are relatively rare, they should be considered as potentially travel-related illnesses. A recent or late trip to an endemic country may guide the clinical suspicion, an early diagnosis, and the institution of effective therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Hsu LY, Wijaya L, Shu-Ting Ng E, Gotuzzo E. Tropical fungal infections. Infect Dis Clin North Am. 2012;26(2):497–512. https://doi.org/10.1016/j.idc.2012.02.004This article summarizes the main characteristics of endemic mycoses and provides a theoretical context of the main diagnostic and treatment methods.

    Article  PubMed  Google Scholar 

  2. Taborda CP, Buccheri R, Benard G, Duarte-Neto AN, Nosanchuk JD, Travassos LR. Paracoccidioides spp. and Histoplasma capsulatum: current and new perspectives for diagnosis and treatment. Curr Top Med Chem. 2018;18(15):1333–48. https://doi.org/10.2174/1568026618666181002112231.

    Article  CAS  PubMed  Google Scholar 

  3. Elston DM. New and emerging infectious diseases. J Am Acad Dermatol. 2005;52(6):1062–8. https://doi.org/10.1016/j.jaad.2005.02.048.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019;44(2):123–9. https://doi.org/10.1111/ced.13642.

    Article  CAS  PubMed  Google Scholar 

  5. Baumgardner DJ. Soil-related bacterial and fungal infections. J Am Board Fam Med. 2012;25(5):734–44. https://doi.org/10.3122/jabfm.2012.05.110226.

    Article  PubMed  Google Scholar 

  6. Di Mango AL, Zanetti G, Penha D, Menna Barreto M, Marchiori E. Endemic pulmonary fungal diseases in immunocompetent patients: an emphasis on thoracic imaging. Expert Rev Respir Med. 2019;13(3):263–77. https://doi.org/10.1080/17476348.2019.1571914.

    Article  CAS  PubMed  Google Scholar 

  7. Hung CY, Hsu AP, Holland SM, Fierer J. A review of innate and adaptive immunity to coccidioidomycosis. Med Mycol. 2019;57(Supplement_1):S85–92. https://doi.org/10.1093/mmy/myy146.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bonifaz A, Vázquez-González D, Perusquía-Ortiz AM. Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis. J Dtsch Dermatol Ges. 2011;9(9):705–15. https://doi.org/10.1111/j.1610-0387.2011.07731.x.

    Article  PubMed  Google Scholar 

  9. •• Tirado-Sánchez A, González GM, Bonifaz A. Endemic mycoses: epidemiology and diagnostic strategies. Expert Rev Anti Infect Ther. 2020 Jul 20;1–13. https://doi.org/10.1080/14787210.2020.1792774This article summarizes the main characteristics of endemic mycoses and provides a context of the main epidemiological and diagnostic methods.

  10. Tonelli GB, Tanure A, Rego FD, Carvalho GML, Stumpp R, Ássimos GR, et al. Leishmania (Viannia) braziliensis infection in wild small mammals in ecotourism area of Brazil. PLoS One. 2017;12(12):e0190315. https://doi.org/10.1371/journal.pone.0190315.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hay RJ. Fungal infections. Clin Dermatol. 2006;24(3):201–12. https://doi.org/10.1016/j.clindermatol.2005.11.011.

    Article  PubMed  Google Scholar 

  12. • Segel MJ, Rozenman J, Lindsley MD, et al. Histoplasmosis in Israeli travelers. Am J Trop Med Hyg. 2015;92(6):1168–72. https://doi.org/10.4269/ajtmh.14-0509The study determines the risk factors associated with histoplasmosis among travelers.

    Article  PubMed  PubMed Central  Google Scholar 

  13. •• Chiodini J, The CDC. Yellow Book app 2018. Travel Med Infect Dis. 2017;19:75–7. https://doi.org/10.1016/j.tmaid.2017.10.014The article provides useful information on the epidemiology of severe mycoses in different geographic regions.

    Article  PubMed  Google Scholar 

  14. •• Salzer HJF, Stoney RJ, Angelo KM, et al. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017. J Travel Med. 2018 Aug 1;25(1). https://doi.org/10.1093/jtm/tay055The article provides useful information on the epidemiology of severe mycoses in different geographic regions.

  15. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015;53(1):3–14. https://doi.org/10.1093/mmy/myu062.

    Article  CAS  PubMed  Google Scholar 

  16. Orofino-Costa R, Macedo PM, Rodrigues AM, Bernardes-Engemann AR. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017;92(5):606–20. https://doi.org/10.1590/abd1806-4841.2017279.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Montenegro H, Rodrigues AM, Dias MA, da Silva EA, Bernardi F, de Camargo ZP. Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in São Paulo. Brazil BMC Vet Res. 2014;10:269. https://doi.org/10.1186/s12917-014-0269-5.

    Article  PubMed  Google Scholar 

  18. Tirado-Sánchez A, Bonifaz A. Nodular Lymphangitis (Sporotrichoid Lymphocutaneous Infections). Clues to Differential Diagnosis. J Fungi (Basel). 2018;4(2):56. https://doi.org/10.3390/jof4020056.

    Article  CAS  Google Scholar 

  19. Bonifaz A, Tirado-Sánchez A. Cutaneous disseminated and extracutaneous sporotrichosis: current status of a complex disease. J Fungi (Basel). 2017;3(1):6. https://doi.org/10.3390/jof3010006.

    Article  CAS  Google Scholar 

  20. Bonifaz A, Vázquez-González D. Sporotrichosis: an update. G Ital Dermatol Venereol. 2010;145(5):659–73.

    CAS  PubMed  Google Scholar 

  21. Estrada-Castañón R, Chávez-López G, Estrada-Chávez G, Bonifaz A. Report of 73 cases of cutaneous sporotrichosis in Mexico. An Bras Dermatol. 2018;93(6):907–9. https://doi.org/10.1590/abd1806-4841.20187726.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bonifaz A, Tirado-Sánchez A, Paredes-Solís V, Cepeda-Valdés R, González GM, Treviño-Rangel RJ, et al. Cutaneous disseminated sporotrichosis: clinical experience of 24 cases. J Eur Acad Dermatol Venereol. 2018;32(2):e77–9. https://doi.org/10.1111/jdv.14533.

    Article  CAS  PubMed  Google Scholar 

  23. Bonifaz A, Toriello C, Araiza J, Ramírez-Soto MC, Tirado-Sánchez A. Sporotrichin skin test for the diagnosis of sporotrichosis. J Fungi (Basel). 2018;4(2):55. https://doi.org/10.3390/jof4020055.

    Article  Google Scholar 

  24. Fernandes GF, Lopes-Bezerra LM, Bernardes-Engemann AR, Schubach TMP, Dias MAG, Pereira SA, et al. Serodiagnosis of sporotrichosis infection in cats by enzyme-linked immunosorbent assay using a specific antigen, SsCBF, and crude exoantigens. Vet Microbiol. 2011;147(3–4):445–9. https://doi.org/10.1016/j.vetmic.2010.07.007.

    Article  PubMed  Google Scholar 

  25. Zhang M, Li F, Li R, Gong J, Zhao F. Fast diagnosis of sporotrichosis caused by Sporothrix globosa, Sporothrix schenckii, and Sporothrix brasiliensis based on multiplex real-time PCR. PLoS Negl Trop Dis. 2019;13(2):e0007219. https://doi.org/10.1371/journal.pntd.0007219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Barros MB, de Almeida PR, Schubach AO. Sporothrix schenckii and sporotrichosis. Clin Microbiol Rev. 2011;24(4):633–54. https://doi.org/10.1128/CMR.00007-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mahajan VK. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract. 2014;2014:272376–13. https://doi.org/10.1155/2014/272376.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fichman V, Valle ACFD, de Macedo PM, et al. Cryosurgery for the treatment of cutaneous sporotrichosis in four pregnant women. PLoS Negl Trop Dis. 2018;12(4):e0006434. https://doi.org/10.1371/journal.pntd.0006434.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ishida K, Castro RA, Torrado JJ, Serrano DR, Borba-Santos LP, Quintella LP, et al. Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis. Med Mycol. 2018;56(3):288–96. https://doi.org/10.1093/mmy/myx040.

    Article  CAS  PubMed  Google Scholar 

  30. Francesconi G, Valle AC, Passos S, Reis R, Galhardo MC. Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis. J Eur Acad Dermatol Venereol. 2009;23(11):1273–6. https://doi.org/10.1111/j.1468-3083.2009.03306.x.

    Article  CAS  PubMed  Google Scholar 

  31. Aung AK, Teh BM, McGrath C, Thompson PJ. Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes. Med Mycol. 2013;51(5):534–44. https://doi.org/10.3109/13693786.2012.751643.

    Article  PubMed  Google Scholar 

  32. Rojas OC, Bonifaz A, Campos C, Treviño-Rangel RJ, González-Álvarez R, González GM. Molecular identification, antifungal susceptibility, and geographic origin of clinical strains of Sporothrix schenckii complex in Mexico. J Fungi (Basel). 2018;4(3):86. https://doi.org/10.3390/jof4030086.

    Article  CAS  Google Scholar 

  33. Córdoba S, Isla G, Szusz W, Vivot W, Hevia A, Davel G, et al. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Mycoses. 2018;61(7):441–8. https://doi.org/10.1111/myc.12760.

    Article  CAS  PubMed  Google Scholar 

  34. Araújo MG, Cirilo NS, Santos SNMBD, Aguilar CR, Guedes ACM. Lobomycosis: a therapeutic challenge. An Bras Dermatol. 2018;93(2):279–81. https://doi.org/10.1590/abd1806-4841.20187044.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Florian MC, Rodrigues DA, de Mendonça SBM, Colombo AL, Tomimori J. Epidemiologic and clinical progression of lobomycosis among Kaiabi Indians, Brazil, 1965-2019. Emerg Infect Dis. 2020;26(5):930–6. https://doi.org/10.3201/eid2605.190958.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Carneiro FP, Maia LB, Moraes MA, et al. Lobomycosis: diagnosis and management of relapsed and multifocal lesions. Diagn Microbiol Infect Dis. 2009;65(1):62–4. https://doi.org/10.1016/j.diagmicrobio.2009.04.013.

    Article  PubMed  Google Scholar 

  37. Francesconi VA, Klein AP, Santos AP, Ramasawmy R, Francesconi F. Lobomycosis: epidemiology, clinical presentation, and management options. Ther Clin Risk Manag. 2014;10:851–60. https://doi.org/10.2147/TCRM.S46251.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005;53(6):931–54. https://doi.org/10.1016/j.jaad.2004.10.883.

    Article  PubMed  Google Scholar 

  39. Pech-Ortiz L, Maya-Aranda S, Hernández-Castro R, Xicohtencatl-Cortes J, Tirado-Sánchez A, Bonifaz A. Lacaziosis (Lobomycosis) From southern Mexico: a case confirmed by molecular biology. Mycopathologia. 2020;185(4):737–739. https://doi.org/10.1007/s11046-020-00464-7.

  40. Arju R, Kothadia JP, Kaminski M, Abraham S, Giashuddin S. Jorge Lobo’s disease: a case of keloidal blastomycosis (lobomycosis) in a nonendemic area. Ther Adv Infect Dis. 2014;2(3–4):91–6. https://doi.org/10.1177/2049936114559919.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Nogueira L, Mendes L, Rodrigues CA, Santos M, Talhari S, Talhari C. Lobomycosis and squamous cell carcinoma. An Bras Dermatol. 2013;88(2):293–5. https://doi.org/10.1590/S0365-05962013000200024.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Arenas CM, Rodriguez-Toro G, Ortiz-Florez A, Serrato I. Lobomycosis in soldiers. Colombia Emerg Infect Dis. 2019;25(4):654–60. https://doi.org/10.3201/eid2504.181403.

    Article  PubMed  Google Scholar 

  43. Talhari S, Talhari C. Lobomycosis. Clin Dermatol. 2012;30(4):420–4. https://doi.org/10.1016/j.clindermatol.2011.09.014.

    Article  PubMed  Google Scholar 

  44. Schaefer AM, Reif JS, Guzmán EA, Bossart GD, Ottuso P, Snyder J, et al. Toward the identification, characterization and experimental culture of Lacazia loboi from Atlantic bottlenose dolphin (Tursiops truncatus). Med Mycol. 2016;54(6):659–65. https://doi.org/10.1093/mmy/myw011.

    Article  CAS  PubMed  Google Scholar 

  45. Camargo ZP, Baruzzi RG, Maeda SM, Floriano MC. Antigenic relationship between Loboa loboi and Paracoccidioides brasiliensis as shown by serological methods. Med Mycol. 1998;36(6):413–7.

    Article  CAS  Google Scholar 

  46. Ramos-E-Silva M, Aguiar-Santos-Vilela F, Cardoso-de-Brito A, Coelho-Carneiro S. Lobomycosis. Literature review and future perspectives. Actas Dermosifiliogr. 2009;100(Suppl 1):92–100. https://doi.org/10.1016/s0001-7310(09)73173-4.

    Article  PubMed  Google Scholar 

  47. Paniz-Mondolfi AE, Reyes Jaimes O, Dávila JL. Lobomycosis in Venezuela. Int J Dermatol. 2007;46(2):180–5. https://doi.org/10.1111/j.1365-4632.2007.02937.x.

    Article  PubMed  Google Scholar 

  48. Bustamante B, Seas C, Salomon M, Bravo F. Lobomycosis successfully treated with posaconazole. Am J Trop Med Hyg. 2013;88(6):1207–8. https://doi.org/10.4269/ajtmh.12-0428.

    Article  PubMed  PubMed Central  Google Scholar 

  49. •• Yeoh DK, Butters C, Curtis N. Endemic mycoses in children. Pediatr Infect Dis J. 2019;38(6S Suppl 1):S52–9. https://doi.org/10.1097/INF.0000000000002324The article presents a broad overview of the main endemic mycoses in children and their study and treatment protocol.

    Article  PubMed  Google Scholar 

  50. Rasamoelina T, Maubon D, Andrianarison M, Ranaivo I, Sendrasoa F, Rakotozandrindrainy N, et al. Endemic chromoblastomycosis caused predominantly by Fonsecaea nubica, Madagascar1. Emerg Infect Dis. 2020;26(6):1201–11. https://doi.org/10.3201/eid2606.191498.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Queiroz-Telles F, de Hoog S, Santos DW, et al. Chromoblastomycosis. Clin Microbiol Rev. 2017;30(1):233–76. https://doi.org/10.1128/CMR.00032-16.

    Article  CAS  PubMed  Google Scholar 

  52. Krzyściak PM, Pindycka-Piaszczyńska M, Piaszczyński M. Chromoblastomycosis. Postepy Dermatol Alergol. 2014;31(5):310–21. https://doi.org/10.5114/pdia.2014.40949.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Sali AP, Sahay A. Chromoblastomycosis of the leg. Pol J Pathol. 2017;68(2):182–4. https://doi.org/10.5114/pjp.2017.69695.

    Article  PubMed  Google Scholar 

  54. Lima BJFS, Voidaleski MF, Gomes RR, et al. Selective isolation of agents of chromoblastomycosis from insect-associated environmental sources. Fungal Biol. 2020;124(3–4):194–204. https://doi.org/10.1016/j.funbio.2020.02.002.

    Article  CAS  PubMed  Google Scholar 

  55. You Z, Yang X, Yu J, Zhang J, Ran Y. Chromoblastomycosis caused by Fonsecaea nubica: first report in northern China and literature review. Mycopathologia. 2019;184(1):97–105. https://doi.org/10.1007/s11046-018-0307-0.

    Article  PubMed  Google Scholar 

  56. Mohanty P, Vivekanandh K, Mohapatra L, Dash G. Squamous cell carcinoma in long-standing chromoblastomycosis. Indian J Dermatol Venereol Leprol. 2017;83(3):363–5. https://doi.org/10.4103/0378-6323.201339.

    Article  PubMed  Google Scholar 

  57. Sideris ER, Ge L. Chromoblastomycosis in immunosuppressed patients. Med J Aust. 2018;209(7):295.

    Article  Google Scholar 

  58. Queiróz AJR, Pereira Domingos F, Antônio JR. Chromoblastomycosis: clinical experience and review of literature. Int J Dermatol. 2018;57(11):1351–5. https://doi.org/10.1111/ijd.14185.

    Article  PubMed  Google Scholar 

  59. Badali H, Fernández-González M, Mousavi B, Illnait-Zaragozi MT, González-Rodríguez JC, de Hoog GS, et al. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba. Mycopathologia. 2013;175(5–6):439–44. https://doi.org/10.1007/s11046-013-9634-3.

    Article  PubMed  Google Scholar 

  60. Bienvenu AL, Picot S. Mycetoma and chromoblastomycosis: perspective for diagnosis improvement using biomarkers. Molecules. 2020;25(11):E2594. https://doi.org/10.3390/molecules25112594.

    Article  CAS  PubMed  Google Scholar 

  61. Sendrasoa FA, Rakotoarisaona MF, Ranaivo IM, Razanakoto NH, Sata M, Raharolahy O, et al. Prise en charge de la chromoblastomycose : un défi dans les pays à ressources limitées comme Madagascar [Management of chromoblastomycosis, a challenge for limited-resource countries such as Madagascar]. Ann Dermatol Venereol. 2020;147(5):377–82. https://doi.org/10.1016/j.annder.2020.01.018.

    Article  PubMed  Google Scholar 

  62. Ranawaka RR, Amarasinghe N, Hewage D. Chromoblastomycosis: combined treatment with pulsed itraconazole therapy and liquid nitrogen cryotherapy. Int J Dermatol. 2009;48(4):397–400. https://doi.org/10.1111/j.1365-4632.2009.03744.x.

    Article  PubMed  Google Scholar 

  63. Kullavanijaya P, Rojanavanich V. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol. 1995;34(11):804–7. https://doi.org/10.1111/j.1365-4362.1995.tb04404.x.

    Article  CAS  PubMed  Google Scholar 

  64. Queiroz-Telles F. Chromoblastomycosis: a neglected tropical disease. Rev Inst Med Trop Sao Paulo. 2015;57(Suppl 19):46–50. https://doi.org/10.1590/S0036-46652015000700009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Verma S, Thakur BK, Raphael V, Thappa DM. Epidemiology of subcutaneous mycoses in Northeast India: a retrospective study. Indian J Dermatol. 2018;63(6):496–501. https://doi.org/10.4103/ijd.IJD_16_18.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Shen XC, Dai XN, Xie ZM, Li P, Lu S, Li JH, et al. A case of chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated by oral itraconazole together with terbinafine. Dermatol Ther (Heidelb). 2020;10(2):321–7. https://doi.org/10.1007/s13555-020-00358-y.

    Article  Google Scholar 

  67. Clark NM, Grim SA, Lynch JP 3rd. Posaconazole: use in the prophylaxis and treatment of fungal infections. Semin Respir Crit Care Med. 2015;36(5):767–85. https://doi.org/10.1055/s-0035-1562902.

    Article  PubMed  Google Scholar 

  68. Criado PR, Careta MF, Valente NY, et al. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy. J Dermatolog Treat. 2011;22(3):167–74. https://doi.org/10.3109/09546630903585074.

    Article  CAS  PubMed  Google Scholar 

  69. Karrakchou B, Boubnane I, Senouci K, Hassam B. Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region. BMC Dermatol. 2020;20(1):1. https://doi.org/10.1186/s12895-019-0097-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Mhmoud NA, Santona A, Fiamma M, Siddig EE, Deligios M, Bakhiet SM, et al. Chaetomium atrobrunneum causing human eumycetoma: the first report. PLoS Negl Trop Dis. 2019;13(5):e0007276. https://doi.org/10.1371/journal.pntd.0007276.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Reis CMS, Reis-Filho EGM. Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review. An Bras Dermatol. 2018;93(1):8–18. https://doi.org/10.1590/abd1806-4841.20187075.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Guerra-Leal JD, Medrano-Danés LA, Montemayor-Martinez A, Pérez-Rodríguez E, Luna-Gurrola CE, Arenas-Guzman R, et al. The importance of diagnostic imaging of mycetoma in the foot. Int J Dermatol. 2019;58(5):600–4. https://doi.org/10.1111/ijd.14351.

    Article  CAS  PubMed  Google Scholar 

  73. Siddig EE, Mhmoud NA, Bakhiet SM, Abdallah OB, Mekki SO, el Dawi NI, et al. The accuracy of histopathological and cytopathological techniques in the identification of the mycetoma causative agents. PLoS Negl Trop Dis. 2019;13(8):e0007056. https://doi.org/10.1371/journal.pntd.0007056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Arastehfar A, Lim W, Daneshnia F, van de Sande WWJ, Fahal AH, Desnos-Ollivier M, et al. Madurella real-time PCR, a novel approach for eumycetoma diagnosis. PLoS Negl Trop Dis. 2020;14(1):e0007845. https://doi.org/10.1371/journal.pntd.0007845.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Salim AO, Mwita CC, Gwer S. Treatment of Madura foot: a systematic review. JBI Database System Rev Implement Rep. 2018;16(7):1519–36. https://doi.org/10.11124/JBISRIR-2017-003433.

    Article  PubMed  Google Scholar 

  76. de l’Escalopier N, Choufani C, Grosset A, et al. Surgical management of mycetoma in Chad: experience from the French forward surgical team deployed in N’Djamena. Traitement chirurgical des mycétomes au Tchad : expérience de l’antenne médico-chirurgicale française déployée à N’Djamena. Med Sante Trop. 2019;29(2):164–9. https://doi.org/10.1684/mst.2019.0896.

    Article  Google Scholar 

  77. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin N Am. 2016;30(1):207–27. https://doi.org/10.1016/j.idc.2015.10.009.

    Article  Google Scholar 

  78. Staffolani S, Buonfrate D, Angheben A, Gobbi F, Giorli G, Guerriero M, et al. Acute histoplasmosis in immunocompetent travelers: a systematic review of literature. BMC Infect Dis. 2018;18(1):673. https://doi.org/10.1186/s12879-018-3476-z.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Meals LT, McKinney WP. Acute pulmonary histoplasmosis: progressive pneumonia resulting from high inoculum exposure. J Ky Med Assoc. 1998;96(7):258–60.

    CAS  PubMed  Google Scholar 

  80. Diaz JH. Environmental and wilderness-related risk factors for histoplasmosis: more than bats in caves. Wilderness Environ Med. 2018;29(4):531–40. https://doi.org/10.1016/j.wem.2018.06.008.

    Article  PubMed  Google Scholar 

  81. • Adenis AA, Valdes A, Cropet C, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18(10):1150–9. https://doi.org/10.1016/S1473-3099(18)30354-2The article presents the main clinical and mortality aspects of histoplasmosis in an endemic area.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Roth MT, Zamith-Miranda D, Nosanchuk JD. Immunization strategies for the control of histoplasmosis. Curr Trop Med Rep. 2019;6(2):35–41. https://doi.org/10.1007/s40475-019-00172-3.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Armstrong PA, Jackson BR, Haselow D, Fields V, Ireland M, Austin C, et al. Multistate epidemiology of histoplasmosis, United States, 2011-2014. Emerg Infect Dis. 2018;24(3):425–31. https://doi.org/10.3201/eid2403.171258.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Morgan J, Cano MV, Feikin DR, et al. A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001. Am J Trop Med Hyg. 2003;69(6):663–9.

    Article  Google Scholar 

  85. Taylor ML, Ruíz-Palacios GM, del Rocío R-MM, et al. Identification of the infectious source of an unusual outbreak of histoplasmosis, in a hotel in Acapulco, state of Guerrero, Mexico. FEMS Immunol Med Microbiol. 2005;45(3):435–41. https://doi.org/10.1016/j.femsim.2005.05.017.

    Article  CAS  PubMed  Google Scholar 

  86. Deepe GS Jr. Outbreaks of histoplasmosis: the spores set sail. PLoS Pathog. 2018;14(9):e1007213. https://doi.org/10.1371/journal.ppat.1007213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Fischer GB, Mocelin H, Severo CB, Oliveira Fde M, Xavier MO, Severo LC. Histoplasmosis in children. Paediatr Respir Rev. 2009;10(4):172–7. https://doi.org/10.1016/j.prrv.2009.08.002.

    Article  PubMed  Google Scholar 

  88. Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol. 2017;55(6):1612–20. https://doi.org/10.1128/JCM.02430-16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115–32. https://doi.org/10.1128/CMR.00027-06.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Buitrago MJ, Martín-Gómez MT. Timely diagnosis of Histoplasmosis in non-endemic countries: a laboratory challenge. Front Microbiol. 2020;11:467. https://doi.org/10.3389/fmicb.2020.00467.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Stockamp NW, Thompson GR 3rd. Coccidioidomycosis. Infect Dis Clin N Am. 2016;30(1):229–46. https://doi.org/10.1016/j.idc.2015.10.008.

    Article  Google Scholar 

  92. Laniado-Laborín R, Arathoon EG, Canteros C, Muñiz-Salazar R, Rendon A. Coccidioidomycosis in Latin America. Med Mycol. 2019;57(Supplement_1):S46–55. https://doi.org/10.1093/mmy/myy037.

    Article  PubMed  Google Scholar 

  93. McCotter OZ, Benedict K, Engelthaler DM, et al. Update on the epidemiology of coccidioidomycosis in the United States. Med Mycol. 2019;57(Supplement_1):S30–40. https://doi.org/10.1093/mmy/myy095.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, et al. Diagnosis and management of systemic endemic mycoses causing pulmonary disease. Respiration. 2018;96(3):283–301. https://doi.org/10.1159/000489501.

    Article  CAS  PubMed  Google Scholar 

  95. Olivere JW, Meier PA, Fraser SL, Morrison WB, Parsons TW, Drehner DM. Coccidioidomycosis--the airborne assault continues: an unusual presentation with a review of the history, epidemiology, and military relevance. Aviat Space Environ Med. 1999;70(8):790–6.

    CAS  PubMed  Google Scholar 

  96. •• Diaz JH. Travel-related risk factors for coccidioidomycosis. J Travel Med. 2018 Jan 1;25(1). https://doi.org/10.1093/jtm/tay027The study determines the risk of acquiring coccidioidomycosis in travelers.

  97. de Perio MA, Materna BL, Sondermeyer Cooksey GL, et al. Occupational coccidioidomycosis surveillance and recent outbreaks in California. Med Mycol. 2019;57(Supplement_1):S41–5. https://doi.org/10.1093/mmy/myy031.

    Article  PubMed  Google Scholar 

  98. Cairns L, Blythe D, Kao A, Pappagianis D, Kaufman L, Kobayashi J, et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis. 2000;30(1):61–4. https://doi.org/10.1086/313602.

    Article  CAS  PubMed  Google Scholar 

  99. Gabe LM, Malo J, Knox KS. Diagnosis and management of coccidioidomycosis. Clin Chest Med. 2017;38(3):417–33. https://doi.org/10.1016/j.ccm.2017.04.005.

    Article  PubMed  Google Scholar 

  100. Bonifaz A, Tirado-Sánchez A, González GM. Cutaneous coccidioidomycosis with tissue arthroconidia. Am J Trop Med Hyg. 2019;100(4):772. https://doi.org/10.4269/ajtmh.18-0700.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Carrasco-Zuber JE, Navarrete-Dechent C, Bonifaz A, Fich F, Vial-Letelier V, Berroeta-Mauriziano D. Cutaneous involvement in the deep mycoses: a review. Part II -systemic mycoses. Afectación cutánea en las micosis profundas: una revisión de la literatura. Parte 2. Micosis sistémicas. Actas Dermosifiliogr. 2016;107(10):816–22. https://doi.org/10.1016/j.ad.2016.06.001.

    Article  CAS  PubMed  Google Scholar 

  102. Dizon D, Mitchell M, Dizon B, Libke R, Peterson MW. The utility of real-time polymerase chain reaction in detecting Coccidioides immitis among clinical specimens in the Central California San Joaquin Valley. Med Mycol. 2019;57(6):688–93. https://doi.org/10.1093/mmy/myy111.

    Article  CAS  PubMed  Google Scholar 

  103. Madgula AS, Covello BR, Singh M, Rao A, Lee JC. Talaromycosis in a patient on nintedanib for interstitial lung disease. Cureus. 2020;12(3):e7215. https://doi.org/10.7759/cureus.7215.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Pongpech N, Rotjanapan P. Absence of cutaneous involvement in disseminated Talaromyces marneffei infection in an AIDS patient: a case report and literature review. Infect Drug Resist. 2019;12:1493–9. https://doi.org/10.2147/IDR.S207819.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Sood N, Gugnani HC. Disseminated Penicillium marneffei infection in a Myanmar refugee from Mizoram state. Indian J Pathol Microbiol. 2010;53(2):361–3. https://doi.org/10.4103/0377-4929.64350.

    Article  PubMed  Google Scholar 

  106. Mohsin J, Khalili SA, van den Ende AHGG, Khamis F, Petersen E, de Hoog GS, et al. Imported talaromycosis in Oman in advanced HIV: a diagnostic challenge outside the endemic areas. Mycopathologia. 2017;182(7–8):739–45. https://doi.org/10.1007/s11046-017-0124-x.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Zhang Y, Cooper B, Gui X, Sherer R, Cao Q. Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature. BMC Infect Dis. 2019;19(1):1003. https://doi.org/10.1186/s12879-019-4634-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Griffiths J, Lopes Colombo A, Denning DW. The case for paracoccidioidomycosis to be accepted as a neglected tropical (fungal) disease. PLoS Negl Trop Dis. 2019;13(5):e0007195. https://doi.org/10.1371/journal.pntd.0007195.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Garcia I, BarbelCarnela R, Dickson S, Diaz S, Rodriguez-Morales AJ, Ravelo M, et al. Paracoccidioidomycosis (South American blastomycosis) of the larynx mimicking carcinoma. Am J Med Sci. 2008 Feb;335(2):149–50. https://doi.org/10.1097/MAJ.0b013e3180a6f1e5.

    Article  PubMed  Google Scholar 

  110. López-Martínez R, Hernández-Hernández F, Méndez-Tovar LJ, Manzano-Gayosso P, Bonifaz A, Arenas R, et al. Paracoccidioidomycosis in Mexico: clinical and epidemiological data from 93 new cases (1972-2012). Mycoses. 2014;57(9):525–30. https://doi.org/10.1111/myc.12190.

    Article  CAS  PubMed  Google Scholar 

  111. Ireland M, Klumb C, Smith K, Scheftel J. Blastomycosis in Minnesota, USA, 1999-2018. Emerg Infect Dis. 2020;26(5):866–75. https://doi.org/10.3201/eid2605.191074.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Ashraf N, Kubat RC, Poplin V, et al. Re-drawing the maps for endemic mycoses. Mycopathologia. 2020;185(5):843–865. https://doi.org/10.1007/s11046-020-00431-2.

  113. Bradsher RW Jr. The endemic mimic: blastomycosis an illness often misdiagnosed. Trans Am Clin Climatol Assoc. 2014;125:188–203.

    PubMed  PubMed Central  Google Scholar 

  114. Akins PT, Jian B. The frozen brain state of Cryptococcus gattii: a globe-trotting, tropical, neurotropic fungus. Neurocrit Care. 2019;30(2):272–9. https://doi.org/10.1007/s12028-018-0538-4.

    Article  PubMed  Google Scholar 

  115. Diaz JH. The disease ecology, epidemiology, clinical manifestations, and management of emerging Cryptococcus gattii complex infections. Wilderness Environ Med. 2020;31(1):101–9. https://doi.org/10.1016/j.wem.2019.10.004.

    Article  PubMed  Google Scholar 

  116. Henao-Martínez AF, Chastain DB, Franco-Paredes C. Treatment of cryptococcosis in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2018;31(4):278–85. https://doi.org/10.1097/QCO.0000000000000458.

    Article  CAS  PubMed  Google Scholar 

  117. Bruner KT, Franco-Paredes C, Henao-Martínez AF, Steele GM, Chastain DB. Cryptococcus gattii complex infections in HIV-infected patients. Southeastern United States Emerg Infect Dis. 2018;24(11):1998–2002. https://doi.org/10.3201/eid2411.180787.

    Article  PubMed  Google Scholar 

  118. Nowak MA, Putynkowska A, Barańska-Rybak W, Czarnacka K, Dębska-Ślizień MA. Cutaneous cryptococcosis: an underlying immunosuppression? Clinical manifestations, pathogenesis, diagnostic examinations and treatment. Postepy Dermatol Alergol. 2020;37(2):154–8. https://doi.org/10.5114/ada.2020.94833.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Lockhart SR, Guarner J. Emerging and reemerging fungal infections. Semin Diagn Pathol. 2019;36(3):177–81. https://doi.org/10.1053/j.semdp.2019.04.010.

    Article  PubMed  Google Scholar 

  120. Gheibi Z, Shayan Z, Joulaei H, Fararouei M, Beheshti S, Shokoohi M. Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study. BMC Infect Dis. 2019;19(1):1094. https://doi.org/10.1186/s12879-019-4676-x.

    Article  PubMed  PubMed Central  Google Scholar 

  121. •• Bourque DL, Solomon DA, Sax PE. Health considerations for HIV-infected international travelers. Curr Infect Dis Rep. 2019;21(5):16. https://doi.org/10.1007/s11908-019-0672-yThe study determines the risk of acquiring systemic infections in travelers with HIV.

    Article  PubMed  Google Scholar 

  122. Pelegrín I, Ayats J, Xiol X, Cuenca-Estrella M, Jucglà A, Boluda S, et al. Disseminated adiaspiromycosis: case report of a liver transplant patient with human immunodeficiency infection, and literature review. Transpl Infect Dis. 2011;13(5):507–14. https://doi.org/10.1111/j.1399-3062.2011.00611.x.

    Article  PubMed  Google Scholar 

  123. Govender NP, Grayson W. Emergomycosis (Emergomyces africanus) in advanced HIV disease. Dermatopathology (Basel). 2019;6(2):63–9. https://doi.org/10.1159/000495405.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Service & Micology Department, Hospital General de México “Dr Eduardo Liceaga”, Dr. Balmis 148, colonia Doctores, PZ: 06720, Mexico City, Mexico

    Andrés Tirado-Sánchez & Alexandro Bonifaz

  2. Department of Medicine, Division of Infectious Diseases, Anschutz Medical Center, University of Colorado, Aurora, CO, USA

    Carlos Franco-Paredes

  3. Instituto Nacional de Salud, Hospital Infantil de México, Federico Gómez, Mexico City, Mexico

    Carlos Franco-Paredes

Authors
  1. Andrés Tirado-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Franco-Paredes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandro Bonifaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandro Bonifaz.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Skin and Soft Tissue Infections in Returning Travelers from the Tropics

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tirado-Sánchez, A., Franco-Paredes, C. & Bonifaz, A. Subcutaneous Mycoses in Travelers. Curr Trop Med Rep 7, 141–152 (2020). https://doi.org/10.1007/s40475-020-00216-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40475-020-00216-z

Keywords

Search

Navigation